BetterLife Pharma (BETRF) Share-based Compensation (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Share-based Compensation of $111564.8 for Q2 2026, up 147.5% year-over-year from $45075.8 in Q2 2025, and up 296.22% quarter-over-quarter from $28157.3 in Q3 2025.
BetterLife Pharma (BETRF) Share-based Compensation (2011 - 2026) Analysis & Trends
BetterLife Pharma's Share-based Compensation history runs 12 years deep, the most recent figure standing at $111564.8 for Q2 2026.
- In Q2 2026, Share-based Compensation rose 147.5% year-over-year to $111564.8; the TTM figure through Apr 2026 stood at $306632.8 (down 12.99% YoY), while the FY2026 annual figure was $122318.1, down 91.53% from the prior year.
- Share-based Compensation for Q2 2026 stood at $111564.8, up from $28157.3 in the prior quarter.
- The five-year high for Share-based Compensation was $1.2 million in Q2 2024, with the low at $17919.7 in Q3 2024.
- The 5-year median for Share-based Compensation is $115061.3 (2023), against an average of $206529.6.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation jumped 1618.87% in 2024, then sank 96.24% in 2025.
- BetterLife Pharma's Share-based Compensation stood at $108614.2 in 2022, then declined by 23.73% to $82840.5 in 2023, then jumped by 102.28% to $167568.9 in 2024, then tumbled by 83.2% to $28157.3 in 2025, then jumped by 296.22% to $111564.8 in 2026.
- Business Quant data shows BETRF's Share-based Compensation at $111564.8 in Q2 2026, $28157.3 in Q3 2025, and $45075.8 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | 111,564.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 111,564.82 |
| Apr 30, 2026 | 111,564.82 |
| Jul 31, 2025 | 28,157.29 |
| Jul 31, 2025 | 28,157.29 |
| Apr 30, 2025 | 45,075.83 |
| Apr 30, 2025 | 45,075.83 |
| Jan 31, 2025 | 121,834.85 |
| Jan 31, 2025 | 121,834.85 |
| Oct 31, 2024 | 167,568.89 |
| Oct 31, 2024 | 167,568.89 |
| Jul 31, 2024 | 17,919.66 |
| Jul 31, 2024 | 17,919.66 |
| Apr 30, 2024 | 1.20 Mn |
| Apr 30, 2024 | 1.20 Mn |
| Jan 31, 2024 | 45,469.20 |
| Jan 31, 2024 | 45,469.20 |
| Oct 31, 2023 | 82,840.48 |
| Oct 31, 2023 | 82,840.48 |
| Jul 31, 2023 | 173,969.62 |
| Jul 31, 2023 | 173,969.62 |